KAWAMINAMI Eiji
No ORCID on file
· 168 papers in corpus
· active 1993-2010
Frequent coauthors
- OHNUKI KEI 84
- YODEN TORU 84
- KUSAYAMA TOSHIYUKI 84
- MATSUMOTO SHUNICHIRO 84
- OKADA MINORU 84
- KINOYAMA ISAO 84
- KUDOU Masafumi 84
- HIRANO MASAAKI 84
- OBITSU KAZUYOSHI 70
- ISOMURA YASUO 56
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …